1. The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review

   • Blythe Adamson
   • Dobromir Dimitrov
   • Ruanne Barnabas

   Systematic Review Open access 30 January 2017 Pages: 1 - 12

   

2. Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey

   • Jeff Richardson
   • Angelo Iezzi
   • Aimee Maxwell

   Original Research Article Open access 04 November 2016 Pages: 13 - 23

   

3. Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

   • Jameel Nazir
   • Malin Berling
   • Adrian Wagg

   Original Research Article Open access 30 January 2017 Pages: 25 - 36

   

4. Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model

   • Barbara de Graaff
   • Lei Si
   • Andrew J. Palmer

   Original Research Article Open access 16 November 2016 Pages: 37 - 51

   

5. A Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy

   • Eric C. Leuthardt
   • Jeff Voigt
   • Pete Sylvester

   Original Research Article Open access 03 November 2016 Pages: 53 - 63

   

6. Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review

   • Ilke Akpinar
   • Philip Jacobs
   • Tien Dat Tran

   Short Communication Open access 08 November 2016 Pages: 65 - 68

   

7. Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”

   • Przemysław Holko

   Letter to the Editor Open access 27 January 2017 Pages: 69 - 70

   

8. Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review”

   • Ilke Akpinar
   • Philip Jacobs
   • Dat T. Tran

   Letter to the Editor Open access 27 January 2017 Pages: 71 - 71